• OFID 2017:4 (Suppl 1) • Poster Abstracts ratio 0.997, P = 0.02. The ROC curve analysis identified a cutoff value of 798 /μL of absolute lymphocyte count (ALC) as a discriminator for the presence of high-level CMV DNAemia, AUC 0.756, 95% CI 0.645-0.867, P = 0.001, with 88.9% sensitivity and 50.4% specificity.
Department of Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, 8 Pediatrics, Nationwide Children's Hospital and the Ohio State University School of Medicine, Columbus, Ohio Session: 252. Pediatric Virology Saturday, October 7, 2017: 12:30 PM Background. All infants under two months of age evaluated for fever or sepsis undergo routine work up at Nationwide Children's Hospital that includes blood, CSF, and mucosal site PCRs for enteroviruses (EV) . We sought to determine the local EV prevalence, clinical characteristics and viral correlates of disease severity in this large population.
Methods. EMRs of all infants 4-60 days of age evaluated for fever or sepsis from January 2015 to September 2016 were reviewed. An in-house developed real-time PCR was used for EV detection. We analyzed cycle threshold values for positive samples.
Results
. Of the 713 patients tested, 151 (21%) patients were positive for EV in at least one site. Majority of the patients (76%) presented between the months of June and October. Median age was 24 days . Median length of stay (LOS) was 40.82 hours . 122 (81%) had fever and 27 (18%) had a rash on admission. Median duration of antibiotic treatment was 2 days (IQR 1.5-2) and median hospital charges were 13,169 USD. CBC values and transaminases were normal. 75 (49%) patients had EV PCR positive in CSF, 120 (79%) in superficial sites, and 109 (72%) in blood and 51 (34%) patients had positive EV PCR in all three sites. 5 patients were admitted to PICU (3.3%), of which 2 had EV detected in CSF. Two patients required pressor support and 3 had seizures. All patients recovered and had no complications at discharge. Among CSF positive patients, median CSF WBC count was 50 October 7, 2017: 12:30 PM Background. Human parechovirus type 3 (HPeV3) and enteroviruses (EVs) are the major viral pathogens causing severe diseases in neonates and young infants. Although two infections typically occur in summer, and initial clinical presentations are similar, differences in clinical and laboratory characteristics of HPeV3-and EVinfections are not well described.
Methods. From January 2014 to December 2016, we prospectively obtained serum and/or cerebrospinal fluid (CSF) samples from febrile neonates and young infants < 4 months suspecting sepsis and meningoencephalitis in Niigata, Japan. RNA/ DNA were extracted from the samples and viral etiologies including HPeV3, EVs, and/or herpes simplex virus were tested using the real-time PCR, followed by genetic sequencing and typing. The comparison was made between HPeV3-and EVs-infected patients based on their medical records and subsequent questionnaires using appropriate statistical analyses.
Results. In total, we obtained 212 serum and 170 CSF samples from 222 patients. HPeV3 and EVs were detected for 56 (25%) and 43 patients (19%) (Figure) , and their median ages were 29 and 24 days (P = 0.58), respectively. HPeV3-infected patients presented with higher median body temperature (38.9 °C vs 38.5 °C, P < 0.001), heart rates (184/minute vs. 161/minute, P = 0.002), peripheral coldness (72% vs. 34%, P < 0.001), skin mottling (65% vs. 23%, P < 0.001), and grunting (22% vs. 5%, P = 0.014) than EVs-infected patients. Additionally, systemic inflammatory response syndrome (SIRS) was more frequently observed in HPeV3-infected patients than in EVs-infected patients (82% vs. 58%, P = 0.009). In the laboratory data, median white blood cell count was lower in HPeV3-infected patients than those in EVs-infected patients (5,200/µL vs. 8,900/µL, P < 0.001). The pleocytosis was observed 58% of EVs-infected patients, but none of the HPeV3-infected patients (P < 0.001); however, HPeV3 RNA was frequently detected than EVs in CSF (90% vs 66%, P = 0.012).
Conclusion. This study showed that HPeV3-infected neonates and young infants presented more severe clinical manifestations than those infected with EVs. Significant tachycardia, poor peripheral circulation, and fulfilling SIRS criteria at the presentation may be the clues considering HPeV3 infection rather than EVs infection.
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No reported disclosures. The maximum CSI score (maxCSI) is a composite, continuous measure of illness severity, based on the degree of abnormality of individual signs and symptoms of a patient's disease or diseases. Importantly, the index contains criteria for influenza as well as related complications.
An Assessment of the Validity of the Comprehensive Severity Index (CSI) as a Measure of Severity of Influenza Infection in Children
Methods. We evaluated the spectrum of influenza illness as measured by maxCSI and assessed its discriminatory power on 321 influenza-infected, otherwise healthy children (0-17 years) enrolled into a prospective study from the emergency department and inpatient units of a pediatric tertiary care hospital and an urban community pediatric clinic. The area under ROC curve (AUC) was computed for univariate (maxCSI as a sole predictor variable) and multivariable logistic regression models of two outcome measures: (1) influenza-related respiratory and extra-respiratory complications based on physician diagnosis and (2) hospitalization. Multivariable models incorporated maxCSI, age, household crowding, influenza type/subtype and antiviral therapy. For each outcome, the Hanley-McNeil method was used to compare AUCs of univariate and multivariable models.
Results. Of the 321 children enrolled, 200 (62.3%) were male and the median age was 5.25 years (range 0.07-17.96). 73 (22.7%) had complications while 61 (19.0%) were hospitalized; the median maxCSI was 25 (range 0-140). In univariate and multivariable modeling, maxCSI was significantly associated with both influenza-related complications and hospitalization (all P < 0.0001). The univariate models discriminated well between children with and without complications ] and between those who were and were not hospitalized [AUC 0.94 (95% CI 0.91-0.97)]. The AUCs for the corresponding multivariable models were not statistically significantly different: 0.90 (95% CI 0.86-0.94; P = 0.13) for complications and 0.94 (95% CI 0.91-0.97; P = 0.34) for hospitalization.
Conclusion. The maxCSI represents a valid continuous outcome measure that can be leveraged to increase statistical power in epidemiologic studies aimed at identifying factors associated with severe influenza.
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